Based on our advanced algorithm, we predict that RARE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $36.69, while the 1-week outlook suggests a value of $36.98. For the 1-month forecast, we project a price of $36.85. Looking further ahead, our 2026 projection estimates a value of $49.73, with a long-term 2030 forecast reaching $102.45. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RARE has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
RARE stock price ended at $36.54 on Thursday, after rising0.25%
The Ultragenyx Pharmaceutical Inc stock price increased by 0.25% on the last trading day (04 Dec 2025), rising from 36.46 to 36.54. Throughout the last trading session, the stock experienced a fluctuation of 3.24% , ranging from a day low of $36.08 to a day high of 37.25. The price has declined in 3 of the last 10 days, resulting in a total change of 14.69% during this period. On the last day, trading volume decrease by -780.23K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.24M shares were traded, amounting to approximately 45.77M.
RARE Technical Signals
RARE(Ultragenyx Pharmaceutical Inc Corp) has 5 buy signals and 4 sell signals now. The current trend is consolidation starting from 2025-12-02. The total price change during this trend is +9.17%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of RARE over the last 5 trading days is 42.61M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
RARE Moving Average Analysis
Ultragenyx Pharmaceutical Inc's overall moving average trend leans more bullish as of Friday, December 5, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $37.93, and $40.31. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $30.20, and $27.81. A break-down below any of these levels will issue sell signals.
RARE Short Selling Analysis
The short sale ratio of Ultragenyx Pharmaceutical Inc(RARE) as of 02 Dec 2025 is 27.80%, rising from last trading day. With increasing price from 33.37 to 33.47. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Sell
4
Buy
5
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Positive
SMA_20 Above SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
1.312
Bullish
Momentum (10 days)
MOM_10 > 0
4.68
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.719
Bullish
Closing price
close > fibonacci_R1
36.54
Bullish
Moving Average
10-day SMA crosses above 200-day SMA
--
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Ultragenyx Pharmaceutical Inc (RARE) is anticipated to change hands in a trading channel between $34.14 and $58.73.
Ultragenyx Pharmaceutical Inc Stock Forecast 2026
Jan 2026: RARE Stock Forecast
Potential ROI: 7.78%
In Jan 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $40.34. The price is predicted to fluctuate between a low of $35.99 and a high of $47.58.
Feb 2026: RARE Stock Forecast
Potential ROI: 30.78%
In Feb 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $48.95. The price is predicted to fluctuate between a low of $42.22 and a high of $56.96.
Mar 2026: RARE Stock Forecast
Potential ROI: 6.39%
In Mar 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $39.82. The price is predicted to fluctuate between a low of $34.50 and a high of $42.84.
Apr 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Apr 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $51.68 and a high of $58.73.
May 2026: RARE Stock Forecast
Potential ROI: 34.70%
In May 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $50.42. The price is predicted to fluctuate between a low of $40.42 and a high of $58.33.
Jun 2026: RARE Stock Forecast
Potential ROI: 14.61%
In Jun 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $42.90. The price is predicted to fluctuate between a low of $34.14 and a high of $50.25.
Jul 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Jul 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $47.44 and a high of $57.99.
Aug 2026: RARE Stock Forecast
Potential ROI: 37.26%
In Aug 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.38. The price is predicted to fluctuate between a low of $48.46 and a high of $55.27.
Sep 2026: RARE Stock Forecast
Potential ROI: 11.67%
In Sep 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $41.80. The price is predicted to fluctuate between a low of $37.62 and a high of $47.67.
Oct 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Oct 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $43.78 and a high of $56.68.
Nov 2026: RARE Stock Forecast
Potential ROI: 38.23%
In Nov 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $50.96 and a high of $51.97.
Dec 2026: RARE Stock Forecast
Potential ROI: 32.87%
In Dec 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $49.73. The price is predicted to fluctuate between a low of $49.40 and a high of $52.29.
RARE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Ultragenyx Pharmaceutical Inc(RARE), our algorithm predicts RARE's 1-month price at $35.31, with an 6.74%upwardshift. Using a similarity score up to 94.03%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Ultragenyx Pharmaceutical Inc (RARE.O) stock, as of Sunday, November 16, 2025 , forecasts a 6.74% change over the next month, based on its high correlation with BWIN.O stock patterns. The similarity between their price movements over the analyzed periods is 94.03%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
RARE
No Data
BWIN
Up: 6.74%Similarity: 94.03%
Name
Similarity
Up/Down
BWIN.O
94.03%
+6.74%
MNKD.O
93.08%
-14.18%
ADM.N
92.68%
-1.74%
GMAB.O
92.51%
-5.50%
RUSHA.O
92.41%
-3.95%
APD.N
92.13%
-7.20%
IVA.O
92.09%
-6.92%
GIII.O
91.92%
-0.38%
MEI.N
91.86%
-3.17%
MT.N
91.76%
-9.27%
RARE Seasonality Analysis
Based on RARE's historical stock price data across all years, the probability of a positive return in December is63.64%, suggesting it maybe an ideal month to invest in RARE. In contrast,Juneoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in June has the highest probability of a positive return (72.73%), while September has the lowest probability (18.18%).
Performance Seasonality
The chart shows Ultragenyx Pharmaceutical Inc. (RARE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Ultragenyx Pharmaceutical Inc (RARE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RARE has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in a year?
The radar chart shows that buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in June has the highest probability of a positive return (72.73%), while September has the lowest probability (18.18%).
How has Ultragenyx Pharmaceutical Inc. (RARE)'s stock price performed over the past three years?
RARE's stock price rose by 5.05% in 2023,decreased by -12.66% in 2024, and went down by 11.2%in 2025.
Which bullish technical signals does RARE have?
Bullish technical signals of RARE include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0, close > fibonacci_R1, 10-day SMA crosses above 200-day SMA.
Is RARE a buy based on overall technical signals summary?
RARE has 5 buy signals and 4 sell signals now. Overall the technical rating for RARE is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of RARE.
What is the trend of Ultragenyx Pharmaceutical Inc (RARE)'s moving average?
Ultragenyx Pharmaceutical Inc's overall moving average trend leans more bullish as of December 05 2025, with 1 negative signals and 3 positive signal.
What is price prediction for RARE stock next month?
The price prediction chart for Ultragenyx Pharmaceutical Inc (RARE.O) stock, as of November 16 2025, forecasts a 6.74% change over the next month, based on its high correlation with BWIN stock patterns. The similarity between their price movements over the analyzed periods is 94.03%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for Ultragenyx Pharmaceutical Inc (RARE) Stock?
In Dec 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $49.73. The price is predicted to fluctuate between a low of $49.40 and a high of $52.29.
What is price prediction 2030 for Ultragenyx Pharmaceutical Inc (RARE) Stock?
In Dec 2030, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $102.45. The price is predicted to fluctuate between a low of $82.35 and a high of $126.92.